Pharmacology of adenosine receptors: the state of the art
Adenosine is a ubiquitous endogenous autacoid whose effects are triggered through the
enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Due to the rapid …
enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Due to the rapid …
Chromone: a valid scaffold in medicinal chemistry
Chromones are a group of naturally occurring compounds that are ubiquitous in nature,
especially in plants. The word chromone is derived from the Greek word chroma, meaning …
especially in plants. The word chromone is derived from the Greek word chroma, meaning …
[HTML][HTML] Caffeine and cardiovascular health
D Turnbull, JV Rodricks, GF Mariano… - Regulatory Toxicology …, 2017 - Elsevier
This report evaluates the scientific literature on caffeine with respect to potential
cardiovascular outcomes, specifically relative risks of total cardiovascular disease (CVD) …
cardiovascular outcomes, specifically relative risks of total cardiovascular disease (CVD) …
Liposome-based drug delivery systems in cancer immunotherapy
Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such
as liposomes, have favorable advantages with the potential to further improve cancer …
as liposomes, have favorable advantages with the potential to further improve cancer …
Immune cell regulation by autocrine purinergic signalling
WG Junger - Nature Reviews Immunology, 2011 - nature.com
Stimulation of almost all mammalian cell types leads to the release of cellular ATP and
autocrine feedback through a diverse array of purinergic receptors. Depending on the types …
autocrine feedback through a diverse array of purinergic receptors. Depending on the types …
Focusing on adenosine receptors as a potential targeted therapy in human diseases
WI Effendi, T Nagano, K Kobayashi, Y Nishimura - Cells, 2020 - mdpi.com
Adenosine is involved in a range of physiological and pathological effects through
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …
Multifunctional lipid bilayer nanocarriers for cancer immunotherapy in heterogeneous tumor microenvironments, combining immunogenic cell death stimuli with …
In addition to the contribution of cancer cells, the solid tumor microenvironment (TME) has a
critical role in determining tumor expansion, antitumor immunity, and the response to …
critical role in determining tumor expansion, antitumor immunity, and the response to …
[HTML][HTML] Recent developments in adenosine receptor ligands and their potential as novel drugs
CE Müller, KA Jacobson - Biochimica et Biophysica Acta (BBA) …, 2011 - Elsevier
Medicinal chemical approaches have been applied to all four of the adenosine receptor
(AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each …
(AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each …
Adenosine A2A Receptor as a Drug Discovery Target
M de Lera Ruiz, YH Lim, J Zheng - Journal of medicinal chemistry, 2014 - ACS Publications
The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been
extensively studied during the past few decades because it offers numerous possibilities for …
extensively studied during the past few decades because it offers numerous possibilities for …
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
B Mathew, DGT Parambi, GE Mathew… - Archiv der …, 2019 - Wiley Online Library
No drug has been approved to prevent neuronal cell loss in patients suffering from
Parkinson's disease (PD) or Alzheimer's disease (AD); despite increased comprehension of …
Parkinson's disease (PD) or Alzheimer's disease (AD); despite increased comprehension of …